VIRPAX Pharmaceuticals specializes in developing new drug delivery systems across various indications in order to increase compliance and maximize the ability to achieve full therapeutic efficacy

What we do is important, but how we do it is just as important. As we drive our business forward, we must not lose sight of our fundamental commitment to doing business the right way. I expect people at all levels to always do the right thing, not just the easy thing – and to be motivated, empowered and supported in doing so.

Only by living up to our core values, wherever VIRPAX Pharmaceuticals Inc. has a presence or an impact, can we maintain the trust of our stakeholders and broader society that is so vital to our reputation and license to do business.

The VIRPAX Pharmaceuticals Inc. Code of Ethics & Business Conduct (the ”Code”) is our guide to understanding how our high level values are to be translated into consistent actions worldwide. It provides guidance about what is expected of each of us as we work to achieve our business goals. I expect you to study it closely and to live by its principles in your day-to-day business activities.

We are all responsible for making sure that nothing, including the need to meet objectives, direct orders from a more senior employee, or pressure from colleagues, ever compromises our commitment to honesty and integrity.

Compliance with this Code is mandatory for all VIRPAX Pharmaceuticals Inc. employees and consultants worldwide. It provides the framework for the application of consistent standards of responsible behavior that will ensure that VIRPAX Pharmaceuticals Inc. is an organization that is valued and respected by society and for which we are all proud to work.

GERALD W. BRUCE
CEO of Virpax Pharmaceuticals

Committee Charters

Governance Documents

Committee Composition

REPORTING CONCERNS

Virpax is committed to maintaining an ethical work environment and to the highest standards of business conduct.

Anyone who has a concern about Virpax’s conduct, or about Virpax’s accounting, internal accounting controls or auditing matters, may communicate that concern to Virpax’s independent directors.

Such communications may be made on a confidential and/or anonymous basis, and may be reported via one of the following steps:

These resources are operated by AnswerNet, an external third-party vendor that has trained professionals to take calls, in confidence, and to report concerns to the appropriate persons for proper handling.

BUSINESS INQUIRIES

Virpax Pharmaceuticals, Inc.
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
610.727.4597
info@virpaxpharma.com

INVESTOR INQUIRIES

Betsy Brod
Affinity Growth Advisors
betsy.brod@affinitygrowth.com

MEDIA INQUIRIES

Public Relations
Virpax Pharmaceuticals, Inc.
pr@virpaxpharma.com